ACXP ▲ +0.7% - Acurx Pharmaceuticals, Inc. $ACXP ACXP - Acurx Pharmaceuticals Announces First Patient Enrolled in PATHFINDER Clinical Trial of Ibezapolstat in Multiply-Recurrent C. difficile Infection 29-SEP-2026 08:01 AM ET